Cristina Granziera

Targets

• AQP4 1
• CD20 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD.

  Neurology, Oct 2026

• Publication

  Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations.

  Nature reviews. Neurology, Sept 2026

• Publication

  Retinal vessel diameters in multiple sclerosis: associations with disability, cardiovascular risk factors and retinal atrophy.

  Multiple sclerosis (Houndmills, Basingstoke, England), Sept 2026

• Publication

  Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

  Nature medicine, Sept 2026

• Publication

  Central vein sign and paramagnetic rim lesions in pediatric-onset multiple sclerosis: a systematic review and meta-analysis.

  Journal of neurology, Aug 2026

• Publication

  Guideline of the German Society of Neurology (DGN): "diagnosis and therapy of HIV-1-associated neurological disorders".

  Neurological research and practice, Aug 2026

• Publication

  Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis.

  Journal of neurology, Aug 2026

• Publication

  Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.

  Science translational medicine, Jul 2026

• Publication

  GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

  Brain : a journal of neurology, Jul 2026

• Publication

  Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities.

  Multiple sclerosis (Houndmills, Basingstoke, England), Jun 2026

• Publication

  Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis.

  Neurology(R) neuroimmunology & neuroinflammation, May 2026

• Publication

  Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.

  Multiple sclerosis (Houndmills, Basingstoke, England), Apr 2026

• Publication

  Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

  Neurology(R) neuroimmunology & neuroinflammation, Apr 2026

• Publication

  Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset.

  Multiple sclerosis (Houndmills, Basingstoke, England), Feb 2026

• Publication

  Use of optical coherence tomography in the care of people with multiple sclerosis in Switzerland: A national survey among neurologists.

  Multiple sclerosis journal - experimental, translational and clinical, Feb 2026

• Publication

  Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View in Multiple Sclerosis.

  Neurology, Jan 2026

• Publication

  Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis.

  Advanced science (Weinheim, Baden-Wurttemberg, Germany), Jan 2026

• Publication

  Accurate quantification of steps from multiple smartphone positions.

  Scientific reports, Jan 2026

• Publication

  Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

  Clinical chemistry and laboratory medicine, Dec 2025

• Publication

  Bridging mesoscopic and microscopic scales in multiple sclerosis: Post mortem brain block multi-contrast 9.4T MRI and histology quantification.

  STAR protocols, Nov 2025

• Publication

  Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

  Multiple sclerosis (Houndmills, Basingstoke, England), Oct 2025

Affiliations

• University of Basel

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.